CHICAGO, IL USA (UroToday.com) - Presented by N.J. Vogelzang,1 S.I. Helle,,2 D.C. Johannessen,3 J.M. O’Sullivan,4 J. Garcia-Vargas,5 C.G. O’Bryan-Tear,6 M. Shan,5 and C. Parker7 at the American Society of Clinical Oncology (ASCO) Annual Meeting - May 31 - June 4, 2013 - McCormick Place - Chicago, IL USA
1Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA; 2Haukeland University Hospital, Bergen, Norway; 3Ullevål University Hospital, Oslo, Norway; 4Centre for Cancer Research and Cell Biology, Queen’s University, Belfast, Ireland; 5Bayer HealthCare, Montville, NJ, USA; 6Algeta ASA, Oslo, Norway; 7The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK
Click HERE to listen to a podcast by Nicholas Vogelzang, MD, one of the participants in this study.